The YECI Committee of the Enterprise will be implementing several key initiatives in support of the Scientific Strategic Plan over the next few years.  The Enterprise is looking for motivated, creative and enthusiastic YECIs to join the Committee to help shape and move these initiatives forward.  The request for applications to join the Enterprise YECI Committee is below.

The Enterprise Board convened via teleconference on 20 October 2010.  Minutes from the meeting are below.

The AIDS Vaccine 2010 conference welcomed six 10th grade students from the Cesar Chavez Public Charter High School for Public Policy in September.   The students and their teachers travelled from Washington, DC to Atlanta, Georgia to attend the conference.  The 10th graders to attend the conference, interact with global health experts and learn about the progress and challenges in developing an HIV vaccine.  

The Enterprise announced that the Harvard Center for AIDS Research (Harvard CFAR) and the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University will serve as the Local Host of AIDS Vaccine 2012.  The conference will be held 9 - 13 September 2012 in Boston, Massachusetts.  The full announcement is below.

The Global HIV Vaccine Enterprise released a statement today on the announcement of the results of the first study of oral pre-exposure prophylaxis (PrEP) for HIV prevention in humans.  "The iPrEx study, is a very important addition to what is the most promising 15 months in the field of HIV prevention research since the epidemic began 27 years ago."  The full statement is available below.

The Council of the Global HIV Vaccine Enterprise issued the below statement today regarding the resignation of one of its founding members, Dr. Margaret (Peggy) Johnston, from the Vaccine Research Program at the U.S. National Institute of Allery and Infectious Diseases.

UNAIDS’ HIV This Week contains a brief on the Scientific Strategic Plan of the Enterprise. The editors note that “a quick read of this forward-looking framework will help you better understand the part that you can play in this global collective undertaking. Together we can succeed in overcoming what some have called the greatest scientific challenge of our time.”

More than 1,100 individuals from around the world attended AIDS Vaccine 2010 (28 September - 1 October) in Atlanta, Georgia. Information on the meeting, including speaker presentations, webcasts of special sessions and press conferences, photos and much more can be found here: http://www.hivvaccineenterprise.org/conference_archive/2010/index.php.

The Global HIV Vaccine Enterprise co-sponsored a satellite on community engagement to identify strategies to enhance research partnerships among diverse stakeholders in HIV biomedical research. The meeting was recorded and can be accessed here (requires free WebEx software installation).